Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Clinical and Translational Radiation Oncology
|
July 30, 2025
Normal tissue outlining guidelines development for soft tissue sarcoma of the extremities
Rita Simões, Sarah Gulliford, Punita Shah, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 25, 2014
Global harmonization of quality assurance naming conventions in radiation therapy clinical trials
Christos Melidis, Walther R Bosch, Joanna Izewska, et al.
BMJ Open
|
December 27, 2023
ARCHERY: a prospective observational study of artificial intelligence-based radiotherapy treatment planning for cervical, head and neck and prostate cancer - study protocol
Ajay Aggarwal, Laurence Edward Court, Peter Hoskin, et al.
BMJ Open
|
January 1, 2021
Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance
Shaista Hafeez, Amanda Webster, Vibeke N Hansen, et al.
BMC Cancer
|
October 8, 2016
DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer
Imran Petkar, Keith Rooney, Justin W G Roe, et al.
Clinical and Translational Radiation Oncology
|
October 14, 2022
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentation
Julia Murray, Clare Cruickshank, Thomas Bird, et al.
Clinical and Translational Radiation Oncology
|
February 24, 2026
PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRT
Angela Pathmanathan, Suneil Jain, John Staffurth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 28, 2023
Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison
Paige A Taylor, Elizabeth Miles, Lone Hoffmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 12, 2026
Identifying high-risk components in online adaptive RT through a multi-centre FMEA to inform clinical trial QA needs
Sarah O Osman, Alex Dunlop, Sophie Alexander, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 7, 2020
Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines
Romaana Mir, Sarah M Kelly, Ying Xiao, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Clinical and Translational Radiation Oncology
|
July 30, 2025
Normal tissue outlining guidelines development for soft tissue sarcoma of the extremities
Rita Simões, Sarah Gulliford, Punita Shah, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 25, 2014
Global harmonization of quality assurance naming conventions in radiation therapy clinical trials
Christos Melidis, Walther R Bosch, Joanna Izewska, et al.
BMJ Open
|
December 27, 2023
ARCHERY: a prospective observational study of artificial intelligence-based radiotherapy treatment planning for cervical, head and neck and prostate cancer - study protocol
Ajay Aggarwal, Laurence Edward Court, Peter Hoskin, et al.
BMJ Open
|
January 1, 2021
Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance
Shaista Hafeez, Amanda Webster, Vibeke N Hansen, et al.
BMC Cancer
|
October 8, 2016
DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer
Imran Petkar, Keith Rooney, Justin W G Roe, et al.
Clinical and Translational Radiation Oncology
|
October 14, 2022
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentation
Julia Murray, Clare Cruickshank, Thomas Bird, et al.
Clinical and Translational Radiation Oncology
|
February 24, 2026
PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRT
Angela Pathmanathan, Suneil Jain, John Staffurth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 28, 2023
Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison
Paige A Taylor, Elizabeth Miles, Lone Hoffmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 12, 2026
Identifying high-risk components in online adaptive RT through a multi-centre FMEA to inform clinical trial QA needs
Sarah O Osman, Alex Dunlop, Sophie Alexander, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 7, 2020
Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines
Romaana Mir, Sarah M Kelly, Ying Xiao, et al.
Page
of 5